These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 15196005)
1. Synthesis and antiplasmodial activity of a cysteine protease-inhibiting biotinylated aziridine-2,3-dicarboxylate. Gelhaus C; Vicik R; Hilgenfeld R; Schmidt CL; Leippe M; Schirmeister T Biol Chem; 2004 May; 385(5):435-8. PubMed ID: 15196005 [TBL] [Abstract][Full Text] [Related]
2. Blocking effect of a biotinylated protease inhibitor on the egress of Plasmodium falciparum merozoites from infected red blood cells. Gelhaus C; Vicik R; Schirmeister T; Leippe M Biol Chem; 2005 May; 386(5):499-502. PubMed ID: 15927894 [TBL] [Abstract][Full Text] [Related]
3. Screening of protease inhibitors as antiplasmodial agents. Part I: Aziridines and epoxides. Schulz F; Gelhaus C; Degel B; Vicik R; Heppner S; Breuning A; Leippe M; Gut J; Rosenthal PJ; Schirmeister T ChemMedChem; 2007 Aug; 2(8):1214-24. PubMed ID: 17562535 [TBL] [Abstract][Full Text] [Related]
4. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid. Schirmeister T J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and antimalarial effects of phenothiazine inhibitors of a Plasmodium falciparum cysteine protease. Domínguez JN; López S; Charris J; Iarruso L; Lobo G; Semenov A; Olson JE; Rosenthal PJ J Med Chem; 1997 Aug; 40(17):2726-32. PubMed ID: 9276017 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory. Desai PV; Patny A; Gut J; Rosenthal PJ; Tekwani B; Srivastava A; Avery M J Med Chem; 2006 Mar; 49(5):1576-84. PubMed ID: 16509575 [TBL] [Abstract][Full Text] [Related]
12. Falcipain inhibitors: optimization studies of the 2-pyrimidinecarbonitrile lead series. Coterón JM; Catterick D; Castro J; Chaparro MJ; Díaz B; Fernández E; Ferrer S; Gamo FJ; Gordo M; Gut J; de las Heras L; Legac J; Marco M; Miguel J; Muñoz V; Porras E; de la Rosa JC; Ruiz JR; Sandoval E; Ventosa P; Rosenthal PJ; Fiandor JM J Med Chem; 2010 Aug; 53(16):6129-52. PubMed ID: 20672841 [TBL] [Abstract][Full Text] [Related]
13. Rational design of aziridine-containing cysteine protease inhibitors with improved potency: studies on inhibition mechanism. Vicik R; Helten H; Schirmeister T; Engels B ChemMedChem; 2006 Sep; 1(9):1021-8. PubMed ID: 16933238 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of cysteine proteases by peptides containing aziridine-2,3-dicarboxylic acid building blocks. Schirmeister T Biopolymers; 1999; 51(1):87-97. PubMed ID: 10380356 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity-relationship studies of thiazolidinediones as antiplasmodial inhibitors of the Plasmodium falciparum cysteine protease falcipain-2. Sharma RK; Younis Y; Mugumbate G; Njoroge M; Gut J; Rosenthal PJ; Chibale K Eur J Med Chem; 2015 Jan; 90():507-18. PubMed ID: 25486422 [TBL] [Abstract][Full Text] [Related]
16. Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database. Desai PV; Patny A; Sabnis Y; Tekwani B; Gut J; Rosenthal P; Srivastava A; Avery M J Med Chem; 2004 Dec; 47(26):6609-15. PubMed ID: 15588096 [TBL] [Abstract][Full Text] [Related]
17. Biosynthesis, localization, and processing of falcipain cysteine proteases of Plasmodium falciparum. Dahl EL; Rosenthal PJ Mol Biochem Parasitol; 2005 Feb; 139(2):205-12. PubMed ID: 15664655 [TBL] [Abstract][Full Text] [Related]